BioPorto A/S publishes prospectus in connection with a rights issue with pre-emptive subscription rights for its existing shareholders

March 7, 2022Announcement no. 2 This announcement and the information contained herein is not for release, publication or distribution, directly or indirectly, in or into the United States, Canada,... | March 7, 2022

Related Keywords

Australia ,United States ,Denmark ,Copenhagen ,Køavn ,Canada ,Hellerup ,Hovedstaden ,Australian ,Canadian ,Danish ,Aktieselskabet Arbejdernes Landsbank ,Formue Nord Markedsneutral ,Neil Goldman ,Bioportoas Bioporto ,Tim Eriksen ,Company Board Of Directors ,Drug Administration ,Rights For The Company ,Nasdaq ,Danish Business Authority ,Company Existing Shareholders ,Danish Financial Supervisory Authority ,Company Announcement ,New Share ,Existing Shareholders ,Pre Emptive Right ,Pre Emptive Rights ,Subscription Price ,Acute Kidney Injury ,Artha Kapitalforvaltning ,Media Invest Danmark ,Ejendomsselskabet Jano Aps ,Remaining Shares ,New Shares ,Nasdaq Copenhagen ,Euronext Securities ,Danish Business ,Subscription Period ,Chief Exectuve ,Chief Financial ,Bioportoas Stock Exchange ,News ,Information ,Press Release ,Arch ,022announcement , ,This ,Announcement ,End ,The ,Ontained ,Wherein ,Us ,Lot ,Or ,Publication ,Dr ,Irectly ,N ,Into ,Nited Biopor Dk0011048619 ,